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ABSTRACT: An enantioselective formal total synthesis of (+)-manzacidin C is described. A key 
feature of the synthesis is the construction of two chiral centers via the asymmetric 1,3-dipolar 





Manzacidins A, B, and C are structurally unique bromopyrrole alkaloids isolated as bioactive 
constituents of the Okinawan sponge, Hymeniacidon sp., collected at the Manza beach of Okinawa 
island in Japan.1 The significant amount of synthetic interest in the manzacidins stems from the 
intriguing structural features of their 1,3-diamine skeletons with a quaternary stereocenter and a 
desire to obtain significant amounts for more comprehensive pharmacological studies.2,3 
Manzacidins A and C have a 2,4-diamino-5-hydroxypentanoic acid skeleton that possesses a 
nitrogen-containing quaternary carbon center at the 4-position. In order to construct such a carbon 
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skeleton, several attempts have been made. Ofune and Shinada were the first to conquer the 
synthesis of manzacidins A and C via the Strecker reaction.4 Ichikawa recently reported their 
synthesis via [3,3]-sigmatropic rearrangement of an allylic cyanate.5 Asymmetric [3+2] 
cycloaddition is an efficient pathway to construct such a skeleton in an optically active form. 
Maruoka and Sibi independently employed asymmetric 1,3-dipolar cycloaddition of a diazoester. 
Leighton reported the enantioselective establishment of two stereocenters via acylhydrazone-alkene 
[3+2] cycloaddition.6–8 
Stereoselective construction of 1,3-diamine skeletons is still a challenging task. Asymmetric 1,3-
dipolar cycloaddition of azomethine imines is generally a useful and effective tool to construct such 
a chiral backbone directly.9 Recently, we developed the asymmetric 1,3-dipolar cycloaddition of 
azomethine imines to allylic and homoallylic alcohols, utilizing either stoichiometric or catalytic 
amounts of diisopropyl (R,R)-tartrate [(R,R)-DIPT] to furnish trans-pyrazolidines with excellent 
regio-, diastereo-, and enantioselectivities.10 If our method could be applied to the cycloaddition of 
methallyl alcohol (2-methylprop-2-en-1-ol) (2), the (S,S)-2,4-diamino-2-methylbutan-1-ol unit B 
could be constructed by the use of (S,S)-DIPT through the cycloadduct 3a as shown in Scheme 1. 
Furthermore, if phenyl-substituted azomethine imine 1a could be used, the oxidation of the phenyl 
ring moiety might provide a ready route to the carboxylic acid functionality as shown in A. In this 
approach, the removal of the C3 unit on the pyrazolidine ring in 3a is another challenge in 
synthesizing manzacidin C. Herein we report the formal total synthesis of manzacidin C based on 
asymmetric 1,3-dipolar cycloaddition of the azomethine imine utilizing (S,S)-DIPT as a chiral 
auxiliary. In addition, the C3 unit on nitrogens of the obtained cycloadduct was successfully 
removed through N–N bond cleavage followed by a retro-Michael addition reaction. 
 


































RESULTS AND DISCUSSION 
First, we examined the asymmetric 1,3-dipolar cycloaddition of phenyl-substituted azomethine 
imine possessing pyrazolidinone skeleton 1a to methallyl alcohol (2) according to the previously 
reported procedure.10a A mixture of methallyl alcohol (2) (1.0 equiv) and (R,R)-DIPT (1.0 equiv) in 
MeCN was treated with MeMgBr (3.0 equiv), followed by the addition of MeCN solution of 
azomethine imine 1a (1.0 equiv) at 0 °C, and then the reaction mixture was heated at 80 °C (eq. 1). 
In the present case of methallyl alcohol (2), cycloaddition proceeded rather slowly in comparison 
with the cycloaddition to prop-2-en-1-ol.11 After 5 d, the corresponding pyrazolidine 3a was 
obtained as a single diastereomer in 48% yield.12 The optical purity of the product was high at 90% 























By the screening of conditions such as the halogen ion in Grignard reagents, solvents (MeCN or 
EtCN), and the addition order of the reagents, we determined the optimal procedure of adding the 
Grignard reagent last to the mixture of the azomethine imine 1a, methallyl alcohol (2), and chiral 
DIPT in MeCN. The cycloaddition afforded the pyrazolidine 3a in almost 60% yield with a 
reproducibly excellent enantioselectivity of 95% ee (Table 1, Entry 1).13,14  
The 1,3-dipolar cycloaddition of several azomethine imines 1b–1e to methallyl alcohol (2) was 
subsequently investigated by the improved procedure. Although the chemical yields were moderate, 
the aryl-substituted azomethine imines 1b and 1c afforded the corresponding cycloadducts 3b and 
3c with high enantioselectivities and complete regio- and diastereoselectivities in each case (Entries 
2 and 3). The cycloaddition of the cyclohexyl- and t-butyl-substituted azomethine imines 2d and 2e 






















Entry R  Yield/% ee/%a 
 1b Ph a 59 95 
2 p-MeC6H4 b 45 91 
3 p-ClC6H4 c 51 91  
4 c-Hex d 64 85 
5 t-Bu e 56 88 
aEnantioselectivities were determined by HPLC analysis (Daicel CHIRALPAK IA). 
b(S,S)-DIPT was used instead of (R,R)-DIPT and (S,S)-isomer of 3 was selectively obtained. 
 
Recrystallization of the cycloadduct 3a obtained by the use of (S,S)-DIPT enhanced the optical 
purity of the cycloadduct 3a up to 99.4% ee.13 The enantiomerically rich 3a was treated with (S)-1-
phenylethyl isocyanate in the presence of a catalytic amount of 4-(N,N-dimethylamino)pyridine 
(DMAP) to give the corresponding carbamate 4a (quant.) (Scheme 2). Recrystallization from 
AcOEt gave diastereomerically pure 4a. The absolute stereochemistry of the pyrazolidine skeleton 
in 4a was determined to be S,S by X-ray crystallographic analysis of its single crystal. Furthermore, 
the cycloadduct 3e (83% ee) obtained by the use of (R,R)-DIPT was also converted to the 
corresponding carbamate 4e (72%). The absolute configuration of the pyrazolidine skeleton in 4e 
was unambiguously confirmed to be R,R by single-crystal X-ray diffraction analysis of the 
diastereomerically pure 4e obtained by its recrystallization from AcOEt. The putative absolute 
configurations of the other products 3b–3d by the use of (R,R)-DIPT were R,R.  
 
 5 
Scheme 2. Determination of Absolute Stereochemistry of 3a and 3e  
















































The precise transition state of the present 1,3-dipolar cycloaddition is not clear yet. The transition 
state models as shown in Figure 1 could be proposed based on the absolute configuration of 3a and 
3e and the previous our results.10 The carbonyl oxygen atom of azomethine imine 1 coordinates to 
the magnesium salt of (R,R)-DIPT as depicted in T1–T4. The nitrogen atom connected with 
carbonyl group attacks to disubstituted internal olefinic carbon of methallyl alcohol (2) (R’ = CH3), 
which might be rather interrupted than the addition to monosubstituted internal carbon of prop-2-
en-1-ol (R’ = H). If the cycloaddition from Si-face of internal olefinic carbon of methallyl alcohol 
in exo- or endo-fashion would be assumed, the azomethine imine unit and double bond in methallyl 
alcohol are located in skew fashion each other. Therefore, overlap between the azomethine imine 
unit and double bond would be rather difficult (T3 and T4). In the case of addition from Re-face, the 
exo-transition state T2 might be disfavored due to the steric congestion between the substituent R in 
the azomethine imine and methylene moiety in methallyl alcohol. As a result, the cycloaddition 







































































(one molar amount of MgBr2 
is omitted in T2 and T4.)  
 
With optimized conditions for the asymmetric 1,3-dipolar addition of azomethine imines to 
methallyl alcohol in hand, we turned our attention to the total synthesis of manzacidin C. One of the 
major challenges in synthesizing manzacidin C is the removal of the three-carbon bridge on the 
pyrazolidine ring. Although many asymmetric 1,3-dipolar cycloadditions of azomethine imines 
possessing pyrazolidinone moieties to olefins have been reported, the conversion of the produced 
fused pyrazolidines to acyclic 1,3-diamine derivatives has not yet been achieved to the best of our 
knowledge.15 We envisaged that retro-Michael addition of the amino group from the propanamide 
moiety of the pyrazolidinone ring could proceed before or after cleavage of the N–N bond.  
After intensive examinations, we decided to cleave the N–N bond first. Thus, the pyrazolidine 3a 
was converted to the corresponding t-butyldimethylsilyl (TBS) ether 5 (Scheme 3). Subsequent 
reduction with Na/NH3 took place smoothly, cleaving the N–N bond to give 6 in 76% yield.16 
Stepwise Boc-protection of the resulting amine and amide moieties was performed to afford the 
corresponding Boc-protected 8-membered azalactam derivative 8 in 95% yield. Although ring-
opening of the N-Boc azalactam 8 by the treatment with phenyl- or ethyl Grignard reagents did not 
proceed,17a a selective nucleophilic attack on the ring carbonyl group by a small nucleophile, a 
hydroxide ion, was achieved by the use of LiOH to afford the N-substituted ω-amino acid.17b The 
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i-Pr2NEt (3 equiv)
dioxane/H2O, rt toluene, reflux
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Next, retro-Michael addition of the carbamate moiety in 9 was examined (Scheme 4). However, the 
desired elimination product 10 was not obtained by the use of several bases (NaH,18a t-BuOK,18b 
etc.). The failure of the retro-Michael reaction strategy led us to examine an alternative method for 
removal of the C3 unit. Thus, we planned to introduce a double bond at the α,β-position of the ester 
and execute an oxidative cleavage. The electrophilic introduction of sulfide moiety commenced by 
treatment with dimethyl disulfide and LiHMDS.19 In this reaction, the desired α-sulfenated product 
11 was not obtained. To our surprise, an unpredicted urea product 12 without the propanoate moiety 
on nitrogen was instead isolated in 25% yield. From the 1H NMR analyses of the byproducts whose 
structures were not determined yet, one of the byproducts contained the methyl propanoate moiety, 
which might be produced via Michael addition of the generated urea anion C to the released methyl 
acrylate (Scheme 5). In addition, the production of 12 was not reproducible. Actually by monitoring 
the reaction by TLC, the urea once formed was consumed to form byproducts if the reaction was 
kept at 25 °C for a prolonged time. We hypothesized that addition of a thiolate anion could trap 
methyl acrylate as a Michael donor to avoid the undesired recombination of the anion C with 
methyl acrylate. The β-elimination reaction from 9 was again examined by the addition of p-
MeC6H4SH. The urea 12 was obtained in improved yield (Table 2, Entry 1); however, the starting 
material 9 was still recovered. The production of β-thiopropanoate 13 (Ar = p-MeC6H4) was 
confirmed by the analyses of 1H NMR spectra of the byproducts.20 When LiHMDS was added to 
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the reaction mixture on three occasions in the presence of 3 equiv of the thiol, the reaction was 
well-controlled to give the urea 12 in 65% yield (Entry 3).  
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THF, –78 °C ~ 25 °C
O
9 12  
Entry m n t/h Yield/% 
1 1.5 2.5  16  40a 
2 1.5  3.0b 19 45 
3 3.0  5.5c 24 65 
aStarting compound 9 was recovered in 14% yield. 
bLiHMDS was added in twice of 2.3 equiv and 0.7 equiv, respectively. 
cLiHMDS was added in three parts of 3.0 equiv, 1.5 equiv, and 1.0 equiv, 
respectively: See experimental section. 
 
The regiochemistry of the Boc group in 12 was confirmed by its transformation to 14 (eq. 2). The 
chemical shift of the benzylic proton in 14 was scarcely shifted from that of 12, which suggests that 


















The remaining main task for the synthesis of manzacidin C was oxidation of the phenyl group into a 
carboxylic acid (Scheme 6). When the urea 12 was subjected to conc. HCl under reflux conditions, 
the hydrolysis proceeded to give a 1,3-diamine hydrochloride 15.21 Boc protection of the resulting 
1,3-diamine moiety gave 16 in 73% yield in 2 steps from 12. Acetylation of the remaining hydroxyl 
group afforded 17. RuCl3/NaIO4 oxidation of the phenyl group in 17 was performed to give the 
corresponding carboxylic acid 18.22 Finally, after rough purification, 18 was subjected to 
saponification followed by acidic workup with an aqueous solution of KHSO4 to afford lactone 19 
in 46% yield. All spectroscopic data of synthetic 19 were identical to those reported in the 
literature.4,5 The synthesis of manzacidin C in three steps from the lactone 19 through 20 has been 
reported by Ohfune and Shinada.4 Thus, a formal total synthesis of manzacidin C has been 
accomplished. 
 















CH2Cl2, 0 °C ~ rt







































In conclusion, we accomplished the formal total synthesis of manzacidin C. Through the 
asymmetric 1,3-dipolar cycloaddition of the azomethine imine possessing a pyrazolidinone skeleton, 
the stereochemistry of two chiral centers could be built in a single step. Within the present synthesis, 
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the C3 unit on the formed pyrazolidine ring could be removed through N–N bond cleavage 
followed by a retro-Michael addition reaction. 
 
EXPERIMENTAL SECTION 
General Method. 1H NMR spectra were recorded on a 400 MHz NMR spectrometer. Chemical 
shifts δ are reported in ppm using TMS as an internal standard. Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), coupling constant (J) 
and integration. 13C NMR spectra were recorded on a 100 MHz NMR spectrometer. The chemical 
shifts are reported relative to CDCl3 (δ = 77.0 ppm). The wavenumbers of maximum absorption 
peaks in IR spectra are presented in cm−1. All of the melting points were measured with a micro 
melting point apparatus. The specific optical rotations were recorded on a polarimeter. HRMS (EI, 
FAB, and DART) spectra were measured with quadrupole and TOF mass spectrometers. 
Dehydrated solvents were purchased for the reactions and used without further desiccation.   
 
(5S,7S)-7-(Hydroxymethyl)-7-methyl-5-phenyltetrahydropyrazolo[1,2-a]pyrazol-1(5H)-one 
(3a): A MeCN (3.0 mL) solution of methallyl alcohol (2) (0.362 g, 5.0 mmol) and MeCN (57 mL) 
were consecutively added to a mixture of (S,S)-DIPT (1.175 g, 5.0 mmol) and azomethine imine 1a 
(0.874 g, 5.0 mmol) under an argon atmosphere. Then the mixture was cooled to 0 °C, and 
methylmagnesium bromide (16.5 mL of 0.91 M solution in THF, 15.0 mmol) was slowly added. 
The reaction was stirred at 0 °C for 0.5 h, at rt for 1 h and then 7 d at 80 °C. The reaction was 
quenched by the addition of a sat. aqueous solution of NH4Cl and the mixture was subsequently 
extracted with CHCl3. The combined extracts were dried over Na2SO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography (SiO2, hexane/AcOEt = 1/1 
to 0:1, then AcOEt/MeOH = 20/1 to 10/1) to give the corresponding pyrazolidine 3a as a solid 
(0.727 g, 59%). Rf = 0.5 (AcOEt/MeOH = 5/1). Mp 111–112 °C. [α]25D –15 (c 0.31, EtOH). The ee 
was determined to be 95% by HPLC (Daicel CHIRALPAK IA, hexane/EtOH = 20/1, 0.75 mL/min, 
254 nm, major 61 min and minor 49 min). 1H NMR (400 MHz, CDCl3): δ = 1.60 (s, 3H), 2.20 (dd, 
J = 12.8, 10.1 Hz, 1H), 2.50 (dd, J = 12.8, 7.3 Hz, 1H), 2.69–2.80 (m, 2H), 2.90–3.02 (m, 1H), 
3.37–3.44 (m, 1H), 3.55 (dd, J = 10.1, 7.3 Hz, 1H), 3.71 (dd, 11.9, 8.6 Hz, 1H), 3.90 (d, J = 11.9 Hz, 
1H), 5.30 (d, J = 8.6 Hz, 1H), 7.28–7.38 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = 22.3, 36.6, 
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50.1, 51.0, 62.3, 68.8, 70.5, 127.0, 128.2, 128.7, 137.4, 164.3. IR (KBr): 3381, 3240, 2970, 2832, 
1669, 1644, 1456, 1432, 1414, 1249, 1187, 1158, 1136, 1063, 1050, 774, 702 cm–1. Anal. Calcd for 
C14H18N2O2: C, 68.27; H, 7.37; N, 11.37. Found: C, 68.19; H, 7.49; N, 11.38. 
In a similar manner, pyrazolidines 3b–3e were obtained from azomethine imines 1b–1e. 
(5R,7R)-7-(Hydroxymethyl)-7-methyl-5-(p-tolyl)tetrahydropyrazolo[1,2-a]pyrazol-1(5H)-one 
(3b): Starting from azomethine imine 1b (391mg, 2.08 mmol) by the use of (R,R)-DIPT (487 mg, 
2.08 mmol), 3b (244 mg, 45%) was obtained as a solid. Rf = 0.6 (AcOEt/MeOH = 10/1). Mp 134–
136 °C. [α]25D +21 (c 0.50, EtOH). The ee was determined to be 91% by HPLC (Daicel 
CHIRALPAK IA, hexane/isopropanol = 40/1, 1.0 mL/min, 254 nm, major 72 min and minor 90 
min). 1H NMR (400 MHz, CDCl3): δ = 1.60 (s, 3H), 2.18 (dd, J = 13.3, 10.1 Hz, 1H), 2.35 (s, 3H), 
2.44 (dd, J = 13.3, 7.3 Hz, 1H), 2.73 (dd, J = 15.6, 8.2 Hz, 1H), 2.76 (dd, J = 8.7, 5.0 Hz, 1H), 2.96 
(m, 1H), 3.41 (dd, J = 8.7, 8.2 Hz, 1H), 3.48 (dd, J = 10.1, 7.3 Hz, 1H), 3.65 (d, J = 11.9 Hz, 1H), 
3.91 (d, J = 11.9 Hz, 1H), 5.31 (brs, 1H), 7.17 (d, J = 8.2 Hz, 2H), 7.25 (d, J = 8.2 Hz, 2H). 13C 
NMR (100 MHz, CDCl3): δ = 21.1, 22.5, 33.6, 50.2, 51.1, 62.5, 69.3, 70.5, 127.1, 129.5, 134.3, 
138.1, 164.5. IR (KBr): 3264, 2975, 2910, 2850, 1663, 1518, 1413, 1151, 1086, 1051, 821 cm–1. 
Anal. Calcd for C15H20N2O2: C, 69.20; H, 7.74; N, 10.76. Found: C, 69.07; H, 7.80; N, 10.75. 
(5R,7R)-5-(4-chlorophenyl)-7-(hydroxymethyl)-7-methyltetrahydropyrazolo[1,2-a]pyrazol-
1(5H)-one (3c): Starting from azomethine imine 1c (426 mg, 2.04 mmol) by the use of (R,R)-DIPT 
(479 mg, 2.04 mmol), 3c (292 mg, 51%) was obtained as a solid. Rf = 0.4 (AcOEt/MeOH = 10/1). 
Mp 107–109 °C. [α]25D +29 (c 0.76, EtOH). The ee was determined to be 91% by HPLC (Daicel 
CHIRALPAK IA, hexane/EtOH = 20/1, 0.75 mL/min, 254 nm, major 78 min and minor 104 min). 
1H NMR (400 MHz, CDCl3): δ = 1.59 (s, 3H), 2.13 (dd, J = 12.8, 10.0 Hz, 1H), 2.49 (dd, J = 12.8, 
7.3 Hz, 1H), 2.69–2.78 (m, 2H), 2.91–3.02 (m, 1H), 3.41(dd, J = 9.2, 7.8 Hz, 1H), 3.52 (dd, J = 
10.0, 7.3 Hz, 1H), 3.70 (d, J = 11.9 Hz, 1H), 3.88 (d, J = 11.9 Hz, 1H), 5.18 (brs, 1H), 7.29–7.35 (m, 
4 H). 13C NMR (100 MHz, CDCl3): δ = 22.5, 36.6, 50.3, 51.0, 62.4, 68.8, 69.8, 128.4, 129.0, 134.0, 
136.0, 164.4. IR (KBr): 3264, 2975, 2910, 2850, 1663, 1518, 1413, 1151, 1086, 1051, 821 cm–1. 
HRMS (EI) calcd for C14H17N2O2Cl [M+] 280.0979, found: 280.0976. 
(5R,7R)-5-Cyclohexyl-7-(hydroxymethyl)-7-methyltetrahydropyrazolo[1,2-a]pyrazol-1(5H)-
one (3d): Starting from azomethine imine 1d (567 mg, 3.15 mmol) by the use of (R,R)-DIPT (737 
mg, 3.15 mmol), 3d (497 mg, 63%) was obtained as an oil. Rf = 0.4 (AcOEt/MeOH = 10/1). [α]25D 
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–31 (c 0.47, EtOH). The ee was determined to be 85% by HPLC (Daicel CHIRALPAK IA, 
hexane/EtOH = 20/1, 0.75 mL/min, 254 nm, major 43 min and minor 49 min). 1H NMR (400 MHz, 
CDCl3): δ = 0.92–1.03 (m, 2H), 1.10–1.28 (m, 3H), 1.39–1.45 (m, 1H), 1.47 (s, 3H), 1.64–1.80 (m, 
5H), 1.94 (dd, J = 12.8, 9.6 Hz, 1H), 2.12 (dd, J = 12.8, 7.8 Hz, 1H), 2.33 (m, 1H), 2.66 (dd, J = 
14.6, 8.2 Hz, 1H), 2.74 (td, J = 8.2, 12.8 Hz, 1H), 2.93 (ddd, J = 14.6, 12.8, 8.2 Hz, 1H), 3.57 (d, J 
= 11.9 Hz, 1H), 3.60 (dd, J = 9.6, 7.8 Hz, 1H), 3.79 (d, J = 11.9 Hz, 1H), 5.46 (br, 1H). 13C NMR 
(100 MHz, CDCl3): δ = 22.1, 25.9, 26.0, 26.2, 28.6, 30.5, 36.6, 40.5, 44.0, 53.7, 61.3, 69.2, 71.6, 
163.4. IR (neat): 3373, 2924, 2855, 1656, 1447, 1440, 1348, 1267, 1188, 1159, 1063, 892, 754 cm–1. 
HRMS (DART) calcd for C14H25N2O2 [(M+H)+] 253.1916, found: 253.1915. 
(5R,7R)-5-(t-Butyl)-7-(hydroxymethyl)-7-methyltetrahydropyrazolo[1,2-a]pyrazol-1(5H)-one 
(3e): Starting from azomethine imine 1e (106 mg, 0.69 mmol) by the use of (R,R)-DIPT (161 mg, 
0.69 mmol), 3e (87 mg, 56%) was obtained as a solid. Rf = 0.6 (AcOEt/MeOH = 10/1). Mp 55–
56 °C. [α]25D –52 (c 0.45, EtOH). The ee was determined to be 88% by HPLC (Daicel 
CHIRALPAK IA, hexane/EtOH = 30/1, 0.75 mL/min, 254 nm, major 42 min and minor 54 min). 
1H NMR (400 MHz, CDCl3): δ = 0.94 (s, 9H), 1.46 (s, 3H), 1.97 (dd, J = 13.3, 9.2 Hz, 1H), 2.05 
(dd, J = 13.3, 8.7 Hz, 1H), 2.35 (dd, J = 8.7, 8.2 Hz, 1H), 2.66 (dd, J = 15.1, 8.2 Hz, 1H), 2.77 (td, J 
= 8.2, 13.3 Hz, 1H), 2.93 (ddd, J = 15.1, 13.3, 8.7 Hz, 1H), 3.57 (d, J = 11.9 Hz, 1H), 3.61 (dd, J = 
9.2, 8.7 Hz, 1H), 3.79 (d, J = 11.9 Hz, 1H), 5.58 (br, 1H). 13C NMR (100 MHz, CDCl3): δ = 21.7, 
26.8, 32.4, 36.9, 42.5, 55.2, 60.6, 69.0, 75.4, 163.1. IR (KBr): 3380, 2961, 2870, 1658, 1442, 1366, 
1244, 1189, 1158, 1130, 1092, 1064, 964, 909, 822, 732 cm–1. HRMS (EI) calcd for C12H22N2O2 
[M+] 226.1681, found: 226.1684. 
((1S,3S)-1-Methyl-7-oxo-3-phenylhexahydropyrazolo[1,2-a]pyrazol-1-yl)methyl ((S)-1-
phenylethyl)carbamate (4a): Recrystallization of 3a (95% ee) from EtOH/hexane gave an 
enantiomerically enriched 3a (99.4% ee). A mixture of the recrystallized 3a (32 mg, 0.13 mmol), 
(S)-1-phenylethyl isocyanate (42 mg, 0.29 mmol), and a catalytic amount of N,N-dimethylpyridin-
4-amine (DMAP) in toluene (1 mL) was stirred at rt for 5 d under an argon atmosphere. The 
mixture was concentrated under reduced pressure. The residue was purified by TLC on SiO2 
(hexane/AcOEt = 1/1) to afford the carbamate 4a (51 mg, quant.). Rf = 0.5 (AcOEt). 
Recrystallization from AcOEt gave the diastereomerically pure 4a. Crystal data: C23H27N3O3, FW = 
393.48, monoclinic, P21 (#4), a = 9.5902(2), b = 9.9373(3), c = 10.7178(3) Å, β = 95.5090(10)°, 
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V = 1016.70(5) Å3, Z = 2, Dcalcd = 1.285 g cm–3, R = 0.0250 (Rw = 0.0660) for 3643 reflections with 
I > 3.00σ(I) and 265 variable parameters. CCDC 1518209 (4a) contains the supplementary 
crystallographic data for this paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. Mp 172–173 °C. [α]25D –
44 (c 0.26, EtOH). 1H NMR (400 MHz, CDCl3): δ = 1.29–1.58 (m, 3H), 1.53 (s, 3H), 2.17 (t, J = 
11.9 Hz, 1H), 2.53–2.76 (m, 3H), 2.82–2.95 (m, 1H), 3.30–3.38 (m, 1H), 3.50–3.57 (m, 1H), 4.42 
(d, J = 11.0 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 4.82–4.91 (m, 1H), 5.18 (brs, 1H), 7.13–7.34 (m, 
10H). 13C NMR (100 MHz, CDCl3): δ = 22.3, 22.5, 37.2, 50.3, 50.7, 51.4, 59.0, 65.5, 69.4, 125.2, 
126.0, 127.0, 127.4, 128.1, 128.6, 137.3, 143.1, 155.2, 163.2. IR (KBr): 3550, 3411, 3240, 2987, 
2939, 1717, 1662, 1617, 1540, 1422, 1374, 1302, 1243, 1155, 1111, 1077, 1058, 762, 703 cm–1. 
Anal. Calcd for C23H27N3O3: C, 70.21; H, 6.92; N, 10.68. Found: C, 70.06; H, 6.98; N, 10.55. 
((1R,3R)-3-(t-butyl)-1-methyl-7-oxohexahydropyrazolo[1,2-a]pyrazol-1-yl)methyl ((S)-1-
phenylethyl)carbamate (4e): A mixture of the 3e (83% ee, 78 mg, 0.34 mmol) obtained by another 
cycloaddition using (R,R)-DIPT, (S)-1-phenylethyl isocyanate (80 mg, 0.54 mmol), and a catalytic 
amount of DMAP in toluene (1 mL) was stirred at rt for 4 d under an argon atmosphere. The 
mixture was concentrated under reduced pressure. The residue was purified by TLC on SiO2 
(AcOEt only) to afford the carbamate 4e (93 mg, 72%). Rf = 0.7 (AcOEt). Recrystallization from 
AcOEt gave the diastereomerically pure 4e. Crystal data: C21H31N3O3, FW = 373.49, orthorhombic, 
P212121 (#19), a = 7.5338(2), b = 15.4969(4), c = 17.6570(5) Å, V = 2061.46(10) Å3, Z = 4, Dcalcd = 
1.203 g cm–3, R = 0.0301 (Rw = 0.0778) for 3901 reflections with I > 3.00σ(I) and 248 variable 
parameters. CCDC 1524360 (4e) contains the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. Mp 183–184 °C. [α]25D –29 (c 0.31, EtOH). In 1H and 13C 
NMR spectra, two isomers of 4e, which might be derived from restricted nitrogen–carbonyl carbon 
bond [N–C(=O)] rotation, were observed in the ratio of 3/1. Major isomer: δ = 0.85 (s, 9H), 1.36–
1.39 (m, 3H), 1.49 (d, J = 6.4 Hz, 3H), 1.86–1.94 (m, 1H), 2.24–2.32 (m, 2H), 2.54 (dd, J = 15.1, 
7.8 Hz, 1H), 2.66–2.74 (m, 1H), 2.86 (dd, J = 14.7, 8.2 Hz, 1H), 3.51 (dd, J = 8.2, 7.8 Hz, 1H), 4.40 
(d, J = 11.0 Hz, 1H), 4.50 (d, J = 11.0 Hz, 1H), 4.80–4.87 (m, 1H), 5.27 (d, J = 7.8 Hz, 1H), 7.18–
7.35 (m, 5H). Selected data of minor isomer; 1.36 (s, 3H), 5.22 (d, J = 6.8 Hz, 1H). 13C NMR (100 
MHz, CDCl3): δ = Major isomer: δ = 22.3, 26.9, 31.8, 37.2, 42.8, 49.6, 50.6, 54.9, 57.7, 65.1, 74.2, 
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125.81, 127.2, 128.6, 144.6, 156.9, 162.8. Selected data of minor isomer; 23.2, 125.76, 126.8, 128.4, 
143.5, 155.2. IR (KBr): 3276, 2961, 1716, 1673, 1627, 1533, 1442, 1366, 1240, 1077, 1063, 910, 
766, 705 cm–1. HRMS (TOF) calcd for C21H32N3O3 [(M+H)+] 374.2444, found: 374.2447. 
(5S,7S)-7-(((t-Butyldimethylsilyl)oxy)methyl)-7-methyl-5-phenyltetrahydropyrazolo[1,2-
a]pyrazol-1(5H)-one (5): The recrystallized 3a (3.0 g, 12 mmol) was dissolved in CH2Cl2 (23 mL) 
and DMAP (278 mg, 2.3 mmol), triethylamine (8.5 mL, 60 mmol), t-butyldimethylsilyl chloride 
(9.18 g, 60 mmol) were successively added and stirred at rt under a nitrogen atmosphere. After 24 h, 
cold water with ice was added and the mixture was allowed to stir for an additional 1 h. The 
reaction mixture was then extracted with CHCl3, and the combined organic extracts were dried over 
Na2SO4. After evaporation of the solvent, the residue was purified by column chromatography 
(SiO2, hexane/AcOEt = 2/1 to 1/10) to give 5 as a solid (4.2 g, 96%). Rf = 0.6 (hexane/EtOAc = 1/1). 
Mp 129–130 °C. [α]25D –28 (c 0.33, EtOH). 1H NMR (400 MHz, CDCl3): δ = 0.117 (s, 3H), 0.120 
(s, 3H), 0.96 (s, 9H), 1.46 (s, 3H), 2.15 (dd, J = 12.4, 11.0 Hz, 1H), 2.59 (dd, J = 15.2, 8.7 Hz, 1H), 
2.66–2.71 (m, 1H), 2.74 (dd, J = 12.4, 6.0 Hz, 1H), 2.93 (ddd, J = 15.2, 13.3, 8.7 Hz, 1H), 3.35 (t, J 
= 8.7 Hz, 1H), 3.55 (d, J = 9.6 Hz, 1H), 3.77 (dd, J = 11.0, 6.0 Hz, 1H), 4.32 (d, J = 9.6 Hz, 1H), 
7.27–7.38 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = –5.6, –5.3, 18.2, 22.1, 25.9, 37.2, 50.8, 51.4, 
60.8, 64.8, 69.7, 127.1, 128.0, 128.6, 138.1, 162.9. IR (KBr): 2950, 2928, 2857, 1676, 1494, 1463, 
1430, 1414, 1254, 1103, 1003, 870, 853, 775, 727, 703 cm–1. Anal. Calcd for C20H32N2O2Si: C, 
66.62; H, 8.95; N, 7.77. Found: C, 66.41; H, 9.12; N, 7.79.  
(6S,8S)-8-(((t-Butyldimethylsilyl)oxy)methyl)-8-methyl-6-phenyl-1,5-diazocan-2-one (6): To 
liquid ammonia (200 mL) under a nitrogen atmosphere was added a THF (5 mL) solution of 5 (3.0 
g, 8.32 mmol) at –78 °C. Then sodium metal (0.57 g, 25.0 mmol) was slowly added in small species 
until the color of solution turned to dark blue.16 After stirring 1 h at –78 °C, the reaction mixture 
was warmed to –33 °C and stirred for an additional 2 h. The reaction was quenched by the addition 
of solid NH4Cl and liquid ammonia was distilled off. The residue was partitioned between CHCl3 
and H2O and the mixture was subsequently extracted with CHCl3. The combined extracts were 
dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography (SiO2, hexane/AcOEt = 1/10 to 1/20, then AcOEt/MeOH = 20/1 to 10/1) to give 6 
as an oil (2.2 g, 76%). Rf = 0.6 (AcOEt/MeOH = 5/1). [α]25D + 19 (c 0.75, EtOH). 1H NMR (400 
MHz, CDCl3): δ = 0.15 (s, 6H), 0.99 (s, 9H), 1.48 (s, 3H), 1.92 (s, 1H), 2.14 (dd, J = 15.6, 3.2 Hz, 
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1H), 2.42 (dd, J = 15.6, 9.6 Hz, 1H), 2.59–2.68 (m, 1H), 2.97 (ddd, J = 13.3, 10.1, 4.6 Hz, 1H), 3.24 
(ddd, J = 13.3, 10.1, 3.6 Hz, 1H), 3.37 (ddd, 13.3, 5.9, 4.6 1H), 3.40 (d, J = 9.6 Hz, 1H), 3.63 (d, J = 
9.6 Hz, 1H), 3.98 (dd, J = 9.6, 3.2 Hz, 1H), 6.33 (s, 1H), 7.32–7.45 (m, 5H). 13C NMR (100 MHz, 
CDCl3): δ = –5.51, –5.46, 18.3, 25.8, 27.0, 37.8, 45.1, 45.5, 55.8, 58.6, 70.3, 126.2, 127.1, 128.8, 
145.7, 175.3. IR (neat): 3368, 3062, 2960, 2928, 2857, 1652, 1471, 1255, 1200, 1103, 839, 778, 701 
cm–1. HRMS (EI) calcd for C20H34N2O2Si [M+] 362.2390, found: 362.2378. 
t-Butyl (2S,4S)- 4-(((t-butyldimethylsilyl)oxy)methyl)-4-methyl-6-oxo-2-phenyl-1,5-diazocane-
1-carboxylate (7): To a dioxane/water (4/1, 20 mL) solution of 6 (4.0 g, 11 mmol) and 
diisopropylethylamine (5.7 mL, 33 mmol), di-t-butyl dicarbonate (4.82 g, 22 mmol) was slowly 
added and the reaction mixture was at rt for 24 h under a nitrogen atmosphere. The reaction mixture 
was then concentrated under reduced pressure. The residue was partitioned between CHCl3 and 
H2O and subsequently extracted with CHCl3. The combined extracts were dried over Na2SO4 and 
concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, 
hexane/AcOEt = 1/5 to 1/20) to give 7 as a solid (4.85 g, 95%). Rf = 0.6 (hexane/AcOEt = 1/2). Mp 
107–109 °C. [α]25D +4 (c 0.32, EtOH). In 1H and 13C NMR spectra, two isomers of 7, which might 
be derived from restricted nitrogen–carbonyl carbon bond [N–C(=O)] rotation, were observed in the 
ratio of 2/1. 1H NMR (400 MHz, CDCl3): Major isomer: δ = 0.10 (s, 3H), 0.12 (s, 3H), 0.92 (s, 9H), 
1.34 (s, 3H), 1.47 (s, 9H), 1.99–2.08 (m, 1H), 2.48 (dd, J = 12.8, 7.8 Hz, 1H), 2.67 (dd, J = 16.0, 
12.8 Hz, 1H), 2.74–2.88 (m, 1H), 2.88–3.01 (m, 1H), 3.40 (d, J = 9.2 Hz, 1H), 4.01 (d, J = 9.2 Hz, 
1H), 4.03–4.16 (m, 1H), 5.74–5.83 (m, 1H), 6.02 (brs, 1H), 7.26–7.36 (m, 5H). Selected data of 
minor isomer; 0.13 (s, 6H), 0.94 (s, 9H). 13C NMR (100 MHz, CDCl3): Major isomer: δ = –5.57, –
5.54, 18.2, 25.80, 28.0, 28.2, 36.5, 37.0, 51.6, 55.6, 55.8, 69.4, 80.6, 126.5, 127.3, 128.5, 140.7, 
156.9, 171.8. Selected data of minor isomer; –5.46, –5.44, 18.3, 25.78, 37.5, 80.3. IR (KBr): 3440, 
2955, 2930, 2857, 1689, 1666, 1473, 1414, 1473, 1414, 1365, 1249, 1218, 1162, 1118, 1048, 837, 
779, 742, 698 cm–1. Anal. Calcd for C25H42N2O4Si: C, 64.89; H, 9.15; N, 6.05. Found: C, 64.66; H, 
9.39; N, 6.06. 
Di-t-butyl (2S,4R)-2-(((t-butyldimethylsilyl)oxy)methyl)-2-methyl-8-oxo-4-phenyl-1,5-
diazocane-1,5-dicarboxylate (8): To a toluene (30 mL) solution of 7 (3.88 g, 8.38 mmol), DMAP 
(1.23 g, 10 mmol) and di-t-butyl dicarbonate (9.14 g, 42 mmol) were added under an argon 
atmosphere and the reaction mixture was refluxed for 24 h. Solvent was removed under reduced 
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pressure. The residue was purified by column chromatography (SiO2, hexane/AcOEt = 5/1 to 2/1) to 
give 8 as an oil (4.69 g, quant.). Rf = 0.4 (hexane/EtOAc = 5/1). [α]25D –128 (c 0.31, EtOH). 1H 
NMR (400 MHz, CDCl3): In 1H and 13C NMR spectra, two isomers of 8, which might be derived 
from restricted nitrogen–carbonyl carbon bond [N–C(=O)] rotation, were observed in the ratio of 
2/1. Major isomer: δ = 0.112 (s, 3H), 0.12 (s, 3H), 0.826 (s, 9H), 1.43 (s, 3H), 1.47 (s, 9H), 1.52 (s, 
9H), 1.85–1.96 (m, 1H), 2.30 (dd, J = 16.0, 3.7 Hz, 1H), 2.32–2.39 (m, 1H), 2.84–2.96 (m, 1H), 
3.43 (td, J = 12.4, 5.0 Hz, 1H), 3.73–3.80 (m, 1H), 4.12 (d, J = 10.1 Hz, 1H), 4.64 (d, J = 10.1 Hz, 
1H), 5.57 (d, J = 11.4 Hz, 1H), 7.20–7.32 (m, 5H). Selected data of minor isomer; 0.106 (s, 3H), 
0.13 (s, 3H), 0.831 (s, 9H), 1.46 (s, 9H), 1.51 (s, 9H), 3.32 (ddd, J = 12.8, 11.4, 3.3 Hz, 1H), 3.43 
(ddd, J = 14.6, 4.6, 2.8 Hz, 1H), 3.95 (d, J = 10.0 Hz, 1H), 4.56 (d, J = 10.0 Hz, 1H), 5.76 (dd, J = 
12.4, 3.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ = Major isomer: δ = –5.3, –5.0, 17.9, 25.1, 25.7, 
27.9, 28.5, 35.4, 41.1, 53.5, 61.8, 66.2, 80.5, 80.9, 81.7, 126.2, 127.1, 128.4, 141.3, 151.6, 154.6, 
183.6. Selected data of minor isomer; –5.6, –5.4, 18.0, 24.4, 25.8, 28.1, 28.4, 35.0, 42.1, 51.9, 61.6, 
65.7, 79.8, 81.6, 126.6, 127.0, 128.3, 141.2, 152.1, 155.1, 183.7. IR (KBr): 2976, 2960, 2857, 1741, 
1712, 1690, 1462, 1406, 1366, 1320, 1254, 1167, 1070, 975, 903, 839, 775, 699 cm–1. HRMS 
(FAB) calcd for C30H51N2O6Si [(M+H)+] 563.3516, found: 563.3515. 
Methyl 3-((t-butoxycarbonyl)((1S,3S)-3-((t-butoxycarbonyl)amino)-4-((t-
butyldimethylsilyl)oxy)-3-methyl-1-phenylbutyl)amino)propanoate (9): To a THF (10 mL) and 
H2O (5 mL) solution of 8 (335 mg, 0.60 mmol), lithium hydroxide (214 mg, 8.93 mmol) was added 
and the reaction mixture was heated at 65 °C for 24 h.17b The reaction was quenched by the addition 
of a sat. aqueous solution of NH4Cl and the mixture was subsequently extracted with CHCl3. The 
combined extracts were dried over Na2SO4 and concentrated under reduced pressure to give the 
crude carboxylic acid as an oil. The resulting carboxylic acid was dissolved in AcOEt and Et2O. 
Subsequently, an Et2O solution of diazomethane was added dropwise until the yellow color of the 
diazomethane solution persisted during several minutes. The solution was then kept under fume 
hood until solvent was completely evaporated. The residue was then purified by column 
chromatography (SiO2, hexane/AcOEt = 5/1 to 2/1) to give 9 as an oil (313 mg, 88%, 2 steps). Rf = 
0.7 (hexane/AcOEt = 2/1). [α]25D –46 (c 0.41, EtOH). 1H NMR (400 MHz, CDCl3): δ = 0.03 (s, 
3H), 0.04 (s, 3H), 0.87 (s, 9H), 1.29 (s, 3H), 1.38 (s, 9H), 1.48 (br s, 9H), 1.60–1.72 (m, 1H), 2.10–
2.52 (m, 3H), 3.12–3.29 (m, 1H), 3.31–3.48 (m, 1H), 3.48–3.59 (m, 1H), 3.56 (s, 3H), 3.68–3.73 (m, 
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1H), 4.50–4.73 (m, 1H), 5.50 (brs, 1H), 7.17–7.33 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = –5.5, 
–5.4, 18.2, 22.3, 25.8, 28.4, 28.5, 33.9, 35.0, 39.4, 51.4, 53.9, 55.9, 67.3, 78.7, 80.0, 127.4, 127.7, 
128.5, 141.5, 154.5, 155.2, 172.0. IR (neat): 3437, 2980, 2954, 2857, 1741 1720, 1691, 1497, 1462, 
1408, 1366, 1253, 1168, 1105, 837, 777, 702 cm–1. HRMS (FAB) calcd for C31H55N2O7Si 
[(M+H)+] 595.3779, found: 595.3773. 
t-Butyl (4S,6S)-4-(((t-butyldimethylsilyl)oxy)methyl)-4-methyl-2-oxo-6-
phenyltetrahydropyrimidine-1(2H)-carboxylate (12): To a THF (3 mL) solution of 
hexamethyldisilazane (210 mg, 1.30 mmol) was added n-butyllithium (1.30 mmol, 0.81 mL of 1.6 
M solution in n-hexane) at –78 °C under an argon atmosphere and the mixture was stirred at –78 °C 
for 1 h to give the first portion of LiHMDS (1.30 mmol). Then a THF (3 mL) solution of        
p-MeC6H4SH (162 mg, 1.30 mmol) was added and the mixture was stirred for 15 min. A THF (3 
mL) solution of 9 (259 mg, 0.43 mmol) to the mixture and the reaction was stirred at –78 °C for 30 
min and at 25 °C for 2 h. After that the reaction was cooled to –78 °C and stirred for 10 min, the 
second portion of LiHMDS (0.65 mmol), prepared from hexamethyldisilazane (106 mg, 0.65 
mmol) and n-butyllithium (0.65 mmol, 0.41 mL of 1.6 M solution in n-hexane) in THF (3 mL), was 
added and stirred for additional 15 min at –78 °C. The reaction was stirred at 25 °C for 2 h. Next 
the reaction was again cooled to –78 °C and the third portion of LiHMDS (0.43 mmol), prepared 
from hexamethyldisilazane (70 mg, 0.43 mmol) and n-butyllithium (0.43 mmol, 0.27 mL of 1.6 M 
solution in n-hexane) in THF (3 mL), was added. Finally, the reaction was warmed to 25 °C and 
stirred for 20 h. The reaction was quenched by the addition of a sat. aqueous solution of NH4Cl and 
the mixture was concentrated under reduced pressure. The residue was partitioned between CHCl3 
and H2O and subsequently extracted with CHCl3. The combined extracts were dried over Na2SO4 
and concentrated under reduced pressure. The residue was purified by column chromatography 
(SiO2, hexane/AcOEt = 5/1 to 2/1) to give 12 as a solid (122 mg, 65%). Rf = 0.4 (hexane/AcOEt = 
2/1). Mp 84–86 °C. [α]25D –32 (c 0.29, EtOH). 1H NMR (400 MHz, CDCl3): δ = 0.08 (s, 3H), 0.09 
(s, 3H), 0.91 (s, 9H), 0.97 (s, 3H), 1.26 (s, 9 H), 1.90 (dd, J = 14.2, 8.7 Hz, 1H), 2.26 (dd, J = 14.2, 
5.5 Hz, 1H), 3.41 (d, J = 9.6 Hz, 1H), 3.51 (d, J = 9.6 Hz, 1H), 5.15 (s, 1H), 5.19 (dd, J = 8.7, 5.5 
Hz, 1H), 7.22–7.35 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = –5.54, –5.48, 18.2, 25.2, 25.8, 27.6, 
39.4, 53.8, 56.7, 69.8, 82.5, 125.4, 127.2, 128.6, 142.5, 151.6, 152.7. IR (KBr): 3480, 2929, 2857, 
 19 
1756, 1638, 1458, 1409, 1367, 1309, 1252, 1146, 1093, 853, 779, 701 cm–1. HRMS (FAB) calcd 
for C23H39N2O4Si [(M+H)+] 435.2679, found: 435.2680. 
Di-t-butyl (4S,6S)-4-(((t-butyldimethylsilyl)oxy)methyl)-4-methyl-2-oxo-6-
phenyldihydropyrimidine-1,3(2H,4H)-dicarboxylate (14): To a toluene (3 mL) solution of 12 
(10 mg, 0.023 mmol) was subsequently added DMAP (3 mg, 0.023 mmol) and di-t-butyl 
dicarbonate (25 mg, 0.12 mmol). The resulting mixture was heated at 90 °C for 1 h under a nitrogen 
atmosphere. The mixture was concentrated under reduced pressure. The residue was purified by 
column chromatography (SiO2, hexane/AcOEt = 10/1 to 5/1) to give the corresponding product 14 
as a solid (10 mg, 81%). Rf = 0.3 (AcOEt). Mp 96–97 °C. [α]25D –20 (c 0.09, EtOH). 1H NMR (400 
MHz, CDCl3): δ = 0.11 (s, 3H), δ = 0.12 (s, 3H), 0.93 (s, 9H), 1.16 (s, 12H), 1.53 (s, 9H), 1.93 (dd, 
J = 13.7, 10.5 Hz, 1H), 2.41 (dd, J = 13.7, 5.0 Hz, 1H), 3.72 (d, J = 9.6 Hz, 1H), 3.97 (d, J = 9.6 Hz, 
1H), 5.13 (dd, J = 10.5, 5.0 Hz, 1H), 7.22–7.35 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = –5.6, –
5.5, 18.3, 22.7, 25.9, 27.4, 27.7, 41.8, 56.9, 58.4, 67.5, 82.7, 83.3, 125.7, 127.3, 128.6, 151.0, 151.2, 
153.2. IR (KBr): 2928, 2855, 1765, 1734, 1673, 1386, 1367, 1247, 1136, 843, 784, 767 cm–1. 
HRMS (FAB) calcd for C28H47N2O6Si [(M+H)+] 535.3203, found: 535.3195. 
Di-t-butyl ((1S,3S)-4-hydroxy-3-methyl-1-phenylbutane-1,3-diyl)dicarbamate (16): A solution 
of 12 (257 mg, 0.59 mmol) in conc. HCl (3.0 mL) was stirred for 2 d at 120 °C (bath temp.).21 The 
mixture was concentrated under reduce pressure to give a crude 1,3-diamine hydrochloride 15 as 
brown solid. The resulting ammonium salt was dissolved in THF (3 mL) and the solution was 
cooled to 0 °C. NaHCO3 (348 mg, 4.14 mmol) was slowly added to the mixture at 0 °C. 
Subsequently, a THF (5 mL) solution of di-t-butyl dicarbonate (645 mg, 2.96 mmol) was added 
slowly during the time of 4 h at 0 °C. The reaction mixture was gradually warmed to rt and stirred 
for 20 h. The reaction mixture was diluted with H2O and extracted with CHCl3. The combined 
extracts were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified 
by column chromatography (SiO2, hexane/AcOEt = 5/1 to 2/1) to give 16 as a solid (170 mg, 73%, 
2 steps). Rf = 0.3 (hexane/AcOEt = 2/1). Mp 117–119 °C. [α]25D –50 (c 0.47, EtOH). 1H NMR (400 
MHz, CDCl3): δ = 1.14 (s, 3H), 1.32 (s, 18H), 2.03–2.07 (m, 1H), 2.17–2.24 (m, 1H), 3.53 (d, J = 
11.9 Hz, 1H), 3.60 (d, J = 11.9 Hz, 1H), 4.60–4.63 (m, 1H), 4.86 (brs, 1H), 5.55 (brs, 1H), 7.11–
7.29 (m, 5H). Signal of one OH or NH proton was not observed clearly. 13C NMR (100 MHz, 
CDCl3): δ = 23.0 28.3, 28.4, 42.3, 51.7, 56.4, 69.5, 79.5, 79.8, 126.1, 127.1, 128.7, 143.7, 155.3, 
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156.1. IR (KBr): 3411, 2979, 2932, 1686, 1510, 1455, 1391, 1366, 1252, 1170 1074, 700 cm–1. 
HRMS (FAB) calcd for C21H35N2O5 [(M+H)+] 395.2546, found: 395.2553. 
(2S,4S)-2,4-Bis((t-butoxycarbonyl)amino)-2-methyl-4-phenylbutyl acetate (17): To a CH2Cl2 (3 
mL) solution of 16 (150 mg, 0.38 mmol) were slowly added Ac2O (0.4 mL) and Et3N (0.5 mL) 
during the time of 2 h at 0 °C under a nitrogen atmosphere and the reaction mixture was gradually 
warmed up to rt and stirred for 22 h. The mixture was concentrated under reduce pressure. The 
residue was purified by column chromatography (SiO2, hexane/AcOEt = 5/1 to 2/1) to give 17 as an 
oil (160 mg, 91%). Rf = 0.5 (hexane/AcOEt = 2/1). [α]25D –46 (c 0.33, EtOH). 1H NMR (400 MHz, 
CDCl3): δ = 1.26 (s, 3H), 1.33 (s, 9H), 1.34 (s, 9H), 1.82–2.10 (m, 1H), 1.97 (s, 3H), 2.17–2.22 (m, 
1H), 4.04 (d, J = 11.0 Hz, 1H), 4.21 (d, J = 11.0 Hz, 1H), 4.72–4.76 (m, 2H), 4.98 (brs, 1H), 7.08–
7.25 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = 20.8, 22.9, 28.3, 42.5, 51.1, 54.2, 68.3, 79.3, 79.5, 
125.9, 127.1, 128.6, 143.7, 154.4, 154.9, 170.6. IR (neat): 3420, 2979, 1742, 1718, 1700, 1521, 
1366, 1247, 1169, 1042, 700 cm–1. HRMS (FAB) calcd for C23H37N2O6 [(M+H)+] 437.2652, found: 
437.2649. 
Di-t-butyl ((3S,5S)-5-methyl-2-oxotetrahydro-2H-pyran-3,5-diyl)dicarbamate (19): To a CCl4 
(2 mL) and MeCN (2 mL) solution of 17 (100 mg, 0.23 mmol) was added a H2O (2 mL) solution of 
RuCl3 hydrate (24 mg, 0.11 mmol) at rt and the reaction mixture was turned to be black after 
stirring. Subsequently, NaIO4 (1.47 g, 6.9 mmol) was added and the black color of the mixture was 
turned to be yellow. The reaction was vigorously stirred at 25 °C for 24 h.22 The reaction mixture 
was filtered and the filtrate was extracted with CHCl3. The combined extracts were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography (SiO2, hexane/AcOEt = 5/1 to 0/1, then AcOEt/MeOH = 10/1) to give the 
corresponding carboxylic acid 18. To a dry MeOH (3 mL) solution of the resulting carboxylic acid 
18 was added K2CO3 powder (158 mg, 1.15 mmol) at rt and the reaction mixture was stirred for 24 
h.22b After the reaction mixture concentrated under reduced pressure, CHCl3/H2O (1/1, v/v, 4 mL) 
was added to the residue and the solution was acidified to pH 3–4 by the addition of 0.1 M KHSO4 
at 0 °C. The reaction mixture was warmed to rt and stirred for 24 h. The mixture was extracted with 
CHCl3. The combined extracts were dried over Na2SO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography (SiO2, hexane/AcOEt = 10/1 to 2/1) to give 19 
as a solid (36 mg, 46%, 3 steps). Rf = 0.3 (hexane/AcOEt = 2/1). Mp 183–184 °C. [α]25D +20 (c 
 21 
0.30, CHCl3); [lit.5, [α]25D +19.1 (c 1.10, CHCl3); lit.4, [α]25D +21.5 (c 1.10, CHCl3)]. 1H NMR (400 
MHz, CDCl3): δ = 1.39 (s, 3H), 1.44 (s, 9H), 1.45 (s, 9H) 1.60–1.68 (m, 1H), 2.68–2.77 (m, 1H), 
4.18–4.26 (m, 1H), 4.51–4.62 (m, 2H), 4.75 (brs, 1H), 5.30 (brs, 1H). 13C NMR (100 MHz, 
CDCl3): δ = 25.9, 28.3, 39.7, 47.8, 50.7, 73.6, 80.4, 154.5, 155.1, 172.0; [lit.
5, δ = 25.8, 28.3, 39.7, 
47.8, 50.7, 73.7, 80.3, 154.5, 155.1, 173.0; lit.4, δ = 28.29, 29.66, 39.66, 47.78, 50.67, 73.65, 80.30, 
154.52, 155.16, 172.05]. IR (KBr): 3444, 2978, 2927, 1718, 1696, 1636, 1519, 1247, 1164, 1045 
cm–1. HRMS (DART) calcd for C16H29N2O6 [(M+H)+] 345.2026, found: 345.2033. 
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